IOBENGUANE I-131 for Neuroblastoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 66 adverse event reports in the FDA FAERS database where IOBENGUANE I-131 was used for Neuroblastoma.
Most Reported Side Effects for IOBENGUANE I-131
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 25 | 20.3% | 0 | 2 |
| Disease progression | 16 | 13.0% | 3 | 3 |
| Mucosal inflammation | 15 | 12.2% | 0 | 0 |
| Thrombocytopenia | 13 | 10.6% | 2 | 1 |
| Anaemia | 12 | 9.8% | 2 | 1 |
| Product use in unapproved indication | 11 | 8.9% | 2 | 0 |
| Platelet count decreased | 8 | 6.5% | 0 | 3 |
| Febrile neutropenia | 7 | 5.7% | 1 | 3 |
| Nausea | 7 | 5.7% | 0 | 3 |
| Pyrexia | 7 | 5.7% | 0 | 4 |
| Vomiting | 7 | 5.7% | 0 | 5 |
| Drug ineffective | 5 | 4.1% | 0 | 1 |
Other Indications for IOBENGUANE I-131
Other Drugs Used for Neuroblastoma
CYCLOPHOSPHAMIDE (1,109)
ETOPOSIDE (1,061)
DOXORUBICIN (725)
CARBOPLATIN (671)
VINCRISTINE (668)
CISPLATIN (633)
MELPHALAN (495)
TOPOTECAN (443)
DINUTUXIMAB (354)
BUSULFAN (252)